Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-12-07FDA Approved: IRBESARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for Irbesartan, a generic angiotensin II receptor blocker. The approval allows Camber to …
-
FDA approval · 2015-12-07FDA Approved: IRBESARTAN — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA confirms approval of the generic irbesartan (IRBESARTAN) under an original ANDA filed by Unichem Pharmaceuticals (USA), Inc. for use in …
-
FDA approval · 2015-12-04FDA Approved: TELMISARTAN — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Telmisartan from Zydus Lifesciences Limited.
-
FDA approval · 2015-12-03FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's supplemental application for amlodipine besylate and benazepril hydrochloride tablets, allowing the marketing of this f…
-
FDA approval · 2015-12-01FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic valsartan/hydrochlorothiazide combination from Mylan Pharmaceuticals Inc. for treatmen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-30FDA Approved: FELODIPINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Felodipine by Glenmark Pharmaceuticals Inc., updating the labeling. It confirms its use for hype…
-
FDA approval · 2015-11-25FDA Approved: TELMISARTAN — Supplemental Application (Chartwell RX, LLC.)
FDA grants supplemental approval for Telmisartan (ANDA078710) filed by Chartwell RX, LLC.
-
FDA approval · 2015-11-25FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Quinapril by Cipla USA Inc., indicating an approval of an additional Quinapril product or labeli…
-
FDA approval · 2015-11-24FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Supplemental Application (Cipla USA Inc.)
The FDA approved a Cipla USA Inc. supplemental application for Quinapril and Hydrochlorothiazide to add the 10/12.5 dosage strength to the p…
-
FDA approval · 2015-11-24FDA Approved: NIFEDIPINE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for nifedipine by Upsher-Smith Laboratories, LLC, facilitating a labeling/strength update for the ge…
-
FDA approval · 2015-11-24FDA Approved: QUINAPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Quinapril hydrochloride from Aurobindo Pharma Limited, enabling the generic product Quinapril hy…
-
FDA approval · 2015-11-20FDA Approved: VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for valsartan submitted by Lupin Pharmaceuticals, Inc.
-
FDA approval · 2015-11-20FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
FDA approves a supplemental application for Losartan Potassium 25 mg from Strides Pharma Science Limited, granting approval for the generic …
-
FDA approval · 2015-11-20FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals.
-
FDA approval · 2015-11-18FDA Approved: IRBESARTAN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for IRBESARTAN filed by Chartwell RX, LLC under the ANDA umbrella, indicating an approved change…
-
FDA approval · 2015-11-18FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the generic combination product lisinopril and hydrochlorothiazide manufactured by Aurobindo Pha…
-
FDA approval · 2015-11-18FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for EDARBYCLOR (azilsartan medoxomil and chlorthalidone) submitted by Azurity Pharmaceuticals (f…
-
FDA approval · 2015-11-18FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide combination from GSMS, Incorporated.
-
FDA approval · 2015-11-17FDA Approved: PRAZOSIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prazosin hydrochloride from Mylan Pharmaceuticals Inc., enabling the generic version to be m…
-
FDA approval · 2015-11-17FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for labetalol hydrochloride (Hospira) authorizing continued marketing of the generic product und…
-
FDA approval · 2015-11-17FDA Approved: AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for amlodipine besylate and atorvastatin calcium from Dr. Reddy's Laboratories Inc, enabling its mar…
-
FDA approval · 2015-11-17FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application from Mylan Pharmaceuticals Inc. for a fixed-dose combination of telmisartan and amlodipine. The …
-
FDA approval · 2015-11-17FDA Approved: IRBESARTAN — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approves a supplemental application for IRBESARTAN submitted by Solco Healthcare U.S., LLC.
-
FDA approval · 2015-11-17FDA Approved: TELMISARTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for telmisartan from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2015-11-16FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic amlodipine and atorvastatin combination from Mylan Pharmaceuticals Inc., under the AND…